Home


UBT-M
HELICOBACTER PYLORI BREATH TEST

Test Code UBT-M 
Test HELICOBACTER PYLORI BREATH TEST 
Methodology Infrared Spectrometry (SP)

NOTE: The Breath Test Collection Kit may be obtained from NorDx with a three-day delay from order to receipt of the kit. 

Description Recommendations for use of the UBT were recently provided by the Digestive Health Initiative, a joint committee assembled with representatives from the American Gastroenterological Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE), and the American Association for the Study of Liver Diseases (AASLD).

These recommendations include the following statements:
"When endoscopy is not clinically indicated, the primary diagnosis of Helicobacter pylori infection can be made serologically or with the Breath Test Collection Kit. When endoscopy is clinically indicated, the primary diagnosis should be established by biopsy urease testing and/or histology. Available evidence suggests that confirmation of Helicobacter pylori eradication is not mandatory in most situations because of costs associated with testing. However, for selected patients with complicated ulcer disease, low-grade gastric mucosa-associated lymphoid tissue lymphoma, and following resection of early gastric cancer, it is appropriate to confirm eradiction. In other situations, the decision to confirm Helicobacter pylori eradication should be made on a case-by-case basis."

This consensus group further specifies that there is no indication to test asymptomatic people and that testing for Helicobacter pylori is only recommended if treatment is planned. 

Specimen Collect breath specimens from a fasting patient using a Meretek UBT™ Breath Test Specimen Collection Kit (Supply T375) supplied by NorDx. A $75 charge per kit will be charged when supplied, and there will be a 3-day delay from order to receipt of the kit. The charge for performance of the test will be assessed when the test is performed.

NOTE:
1. Patients should not have taken bismuth/tritec, antibiotics, proton-pump inhibitors (e.g., Prilosec®, Prevacid®, Aciphex®, Protonix®, Nexium®) or Pepto-Bismol for 2 weeks prior to testing.
2. If taking prescription levels of the H2-receptor antagonists (Pepcid®, Tagamet®, Axid®, Zantac®), suggest moving to the low-dose, over-the-counter strength for 2 weeks prior to test, and not taking the dose on the day of the test.
3. Carafate (Sucrafate®) does not interfere with the test. 

Reference Values Negative (reported as positive or negative) 
Analytic Time 1 Day 
Day(s) Test Set Up Monday through Saturday 
CPT Code(s) 83013